At LuminoDx with a commitment to precision medicine, and a combined 35 years of CRO experience, we are at the forefront of driving advancements in liquid biopsy translational science, clinical research, and diagnostics. At LuminoDx we specialize in leveraging cutting edge technologies for exosome isolation and downstream molecular analysis.  This includes high content proteomics with O-link’s Signature platform (certified O-link service provider), flow cytometry, and advanced nucleic acid detection platforms like ddPCR.

LuminoDx Inc.

Org chart

Teams

Offices